ATL Technology Acquires BioVision Technologies, LLC

ATL Technology Acquires Manufacturing Operations of Gyrus Medical Limited

April 24, 2023

Medical Devices

ATL Technology has acquired the manufacturing operations of Gyrus Medical Limited in Cardiff from Olympus Winter & Ibe GmbH (Olympus Surgical Technologies Europe). The deal expands ATL's European manufacturing footprint and engineering capabilities to support medical device OEM customers.

Bureau Veritas Acquires Advanced Testing Laboratory (ATL)

June 28, 2022

Professional Services

Bureau Veritas has acquired Advanced Testing Laboratory (ATL), a Cincinnati-based scientific sourcing and laboratory testing services provider serving consumer healthcare, cosmetics/personal care and medical device markets. The acquisition expands Bureau Veritas' Consumer Products Services capabilities and North American footprint; ATL employs over 500 people and generated approximately €31 million in revenue in 2021.

CACI International Acquires Ascent Vision Technologies

August 12, 2020

Aerospace & Defense

CACI International Inc. has acquired Ascent Vision Technologies (AVT), a provider of gyro‑stabilized EO/IR imaging systems and counter‑UAS solutions. The acquisition augments CACI's ISR, electronic warfare and system integration capabilities, expanding its offerings for U.S. military and international defense customers.

VaLogic Bio Acquires Air Systems Technologies (AST)

July 30, 2025

Healthcare Services

VaLogic Bio has acquired Air Systems Technologies (AST), a cleanroom certification and biosafety-testing specialist headquartered in Avon, Massachusetts. The acquisition expands VaLogic's service offerings for life sciences customers and strengthens its presence across the Mid-Atlantic and New England; AST will continue operating in Avon as VaLogic Bio.

Bausch + Lomb Acquires Elios Vision

December 11, 2024

Medical Devices

Bausch + Lomb Corporation (through an affiliate) has acquired Elios Vision, Inc., developer of the ELIOS excimer-laser MIGS system, expanding Bausch + Lomb's glaucoma surgical capabilities and complementing its cataract surgery portfolio. The ELIOS technology, currently CE marked and marketed in the EU, is undergoing pursuit of FDA approval and will be commercialized more broadly through Bausch + Lomb's global cataract surgery channels.

Olympus to Acquire Odin Vision

December 20, 2022

Medical Devices

Olympus Corporation has signed a definitive agreement to acquire London-based Odin Vision, a cloud-AI endoscopy company, for up to GBP 66 million in upfront and milestone payments. The purchase is part of Olympus' broader digital strategy to integrate AI-driven detection, diagnostics, and cloud-enabled workflow solutions into its Digital Endosuite to improve clinical decision-making and patient outcomes.